Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships

September 30, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 30 /- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has engaged Fabiani & Company to assist in the establishment of federal partnerships...

Winner Medical Launches Its Own PurCotton® B2C Website

September 30, 2010 4:31 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Sept. 30 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner Medical"), a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton® materials for the medical and consumer products industries in China, today announced...

Covance and Sanofi-Aventis Sign Definitive Agreements for 10-Year Strategic R & D Alliance

September 30, 2010 1:32 am | by Bio-Medicine.Org | News | Comments

PRINCETON, N.J., Sept. 30 /- Covance Inc. (NYSE: CVD ) today announced the signing of definitive agreements with sanofi-aventis (EURONEXT: SAN and NYSE: SNY ) for Covance to become sanofi-aventis' R&D partner. Over the next ten years, Covance expects to provide drug development...

Advertisement

MedPro Imaging Launches Ultrasound Transducer Repair Division

September 29, 2010 8:36 am | by Bio-Medicine.Org | News | Comments

WAUKESHA, Wis., Sept. 29 /- MedPro Imaging, a premier provider of economic ultrasound solutions, today announced the launch of its Ultrasound Transducer Repair Division.  Based on proprietary repair technology not previously available in the U.S. market, MedPro Imaging will offer...

African-Americans Equally Likely to Benefit from Erlotinib and Other Targeted Lung Cancer Therapy

September 28, 2010 1:34 pm | by AACR | News | Comments

DENVER — African-American patients with non-small cell lung cancer are just as likely to display an epidermal growth factor receptor (EGFR) mutation in tumors as Caucasians, which suggests they are as likely to benefit from targeted therapies such as erlotinib.

Reportlinker Adds Global Pico Projector By Application, Technology & Products Market (2010-2014)

September 28, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 28 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Pico Projector By Application, Technology & Products Market (2010-2014)....

Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition

September 28, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 28 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition http://www.reportlinker.com/p0304775/Global-In-Vitro-Diagnostics-IVD-Market-Report-2010-Edition.html The global...

Reportlinker Adds Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015

September 28, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 28 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Magnetic Resonance Imaging (MRI) Systems Market, 2010 - 2015 http://www.reportlinker.com/p0304768/Global-Magnetic-Resonance-Imaging-MRI-Systems-Market-2010---2015.html...

Advertisement

Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results

September 28, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

FARMINGDALE, N.Y., Sept. 28 /- Misonix, Inc. (Nasdaq: MSON ), a developer of state of the art, ultrasonic medical device technology, which worldwide is used for acute health conditions, today reported financial results for the fourth fiscal quarter and year ending June 30, 2010....

Reportlinker Adds Diagnostic Imaging Equipment - Emerging Markets (BRIC- Brazil, Russia, India, and China) 2010 - 2015".

September 28, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 28 /- Reportlinker.com announces that a new market research report is available in its catalogue: Diagnostic Imaging Equipment - Emerging Markets (BRIC- Brazil, Russia, India, and China) 2010 – 2015"....

Luminex to Host MAGPIX Road Shows Throughout the U.S. and Europe

September 28, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Sept. 28 /- Luminex Corporation (Nasdaq: LMNX ), today announced the initial dates and locations for the MAGPIX® road show, a multinational tour designed to showcase the recently-launched MAGPIX analytical instrument that is capable of performing up to 50 tests on a...

Millstone Medical Outsourcing Makes Strategic Hires in Memphis

September 28, 2010 10:32 am | by Bio-Medicine.Org | News | Comments

FALL RIVER , Mass., Sept. 28 /- Millstone Medical Outsourcing announced today that the company hired three new professionals to support operations in the Memphis, TN, facility.  Perry C. Rothrock, III, MD, was hired as a consultant to serve as Medical Director.  His role will be...

Open Door Family Medical Centers Named Top Community Health Center in Nation for Use of Information Technology

September 28, 2010 7:33 am | by Bio-Medicine.Org | News | Comments

OSSINING, N.Y., Sept. 28 /- Open Door Family Medical Centers ( http://opendoormedical.org ) a federally qualified community health center providing quality health care to the under-served, uninsured and underinsured residents of Westchester County has received the HIMSS Community Health...

Advertisement

Delcath to Present at the William Blair Emerging Growth Stock Conference

September 28, 2010 3:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 28 /- Delcath Systems, Inc. (Nasdaq: DCTH ) announced today that management will present at the William Blair Emerging Growth Stock Conference on Tuesday, October 5, 2010 at 8:45 a.m. ET in New York, NY. Mr. David McDonald, Chief Financial Officer, will provide an overview...

Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion

September 28, 2010 3:35 am | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa., Sept. 28 /- Diversifies Revenue Streams and Boosts Scale in Existing Generics Business, and Strengthens Core Pain Franchise Transaction Expected to be Immediately Accretive to Adjusted Diluted Earnings per Share by $0.40 in First Full Year After Close Company Reiterates...

PAREXEL International to Present at William Blair Emerging Growth Stock Conference

September 28, 2010 3:35 am | by Bio-Medicine.Org | News | Comments

BOSTON, Sept. 28 /- PAREXEL International Corporation (Nasdaq: PRXL ) announced today it will be presenting at the William Blair Emerging Growth Stock Conference in New York.  James Winschel, Senior Vice President and Chief Financial Officer will be making a presentation on PAREXEL...

Incisive Surgical Issued Notice of Allowance for Key Absorbable Skin Stapler Patent

September 28, 2010 3:35 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Sept. 28 /- Incisive Surgical, Inc. today announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for another key patent application, "Mechanical Method and Apparatus for Tissue Fastening."  The allowed claims include subject matter covering the...

Ultrasound device stimulates brain from 'outside in'

September 27, 2010 12:32 pm | by Arizona State University | News | Comments

ASU scientist William Tyler and his team's research with "transcranial pulsed ultrasound," which stimulates brain circuits "from the outside in," has captured the attention of the Pentagon and Wired magazine.read more

Millions of Americans Are Living With Hidden Epidemics of Hepatitis B and C, Top Experts Warn

September 27, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Sept. 27 /- The American Association for the Study of Liver Diseases (AASLD) and the Trust for America's Health (TFAH) issued a new report today calling for action to be taken to transform how the country deals with viral hepatitis – to help identify millions of...

Texoma Medical Center Selects Skytron, Powered by Awarepoint, for Their Real-time Location System (RTLS)

September 27, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

GRAND RAPIDS, Mich. and SAN DIEGO, Sept. 27 /- Skytron Inc., a division of the KMW Group,  and Awarepoint Corp. today announced Texoma Medical Center has implemented the companies' Real-time Location System ( RTLS )  to automatically track and manage over 200 hospital assets, as...

MedWOW International Medical Equipment Platform Adds Seller Ministores

September 27, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

NICOSIA, Cyprus, Sept. 27 /- MedWOW.com is pleased to announce the addition of its newest value-added feature, focused on sellers of new and used medical equipment , strengthening their exposure to potential buyers. Each seller is entitled to a free ministore, featuring their inventory. A...

Hospira Receives TGA Approval for Nivestim™, Australia's First Biosimilar Filgrastim

September 26, 2010 4:35 pm | by Bio-Medicine.Org | News | Comments

MELBOURNE, Australia, Sept. 26 /- Hospira, Inc. (NYSE: HSP ), the world leader in generic injectable pharmaceuticals, today announced that it has received Australian Therapeutic Goods Administration (TGA) approval for its biosimilar filgrastim product, Nivestim™. Nivestim has been...

Duluth-Area Plasma Donors to be Recognized for Lifesaving Contribution in Fight Against Rare Diseases

September 25, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

DULUTH, Minn., Sept. 25 /- CSL Plasma , one of the world's largest collectors of human plasma, is honoring donors from the Duluth area today as part of a statewide observance of "Plasma Protein Therapies Month." According to Randy Furby, Senior Vice President and General Manager of CSL...

HORIZONS-AMI Trial Provides Superior Outcomes Data at Three Years with TAXUS® Drug-Eluting Stent in Heart Attack Patients

September 25, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

NATICK, Mass., Sept. 25 /- Boston Scientific Corporation (NYSE: BSX ) today announced three-year follow-up data from the HORIZONS-AMI trial.  The trial, sponsored by the Cardiovascular Research Foundation (CRF) with grant support from Boston Scientific and The Medicines Company...

Data from Multiple Clinical Trials of OrbusNeich's Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT ...

September 25, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Sept. 25 /- OrbusNeich today announced that clinical trial results highlighting the company's Genous Bio-engineered R stent and its endothelial progenitor cell (EPC) capture technology across challenging patient subsets were presented during a symposium titled "EPC Capture...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading